SP

Shilpa Pranaykumar Patre

Active Director Director DIN 10265235
DIN 10265235 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Shilpa Pranaykumar Patre

Data last updated:

Shilpa Pranaykumar Patre is a Director at Ashilp Medpharma Private Limited (since 2023). The company operates in Paper.

DIN 10265235
Primary Designation Director
Industry Paper
First Appointment 03 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ashilp Medpharma Private Limited U21001MH2023PTC407985
Director03 Aug 20232023Active

Board colleagues of Shilpa Pranaykumar Patre

NameDINCompanyDesignation
Asitmooni Bhagwan Kamble10265236Ashilp Medpharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ashilp Medpharma Private Limited
Premium access

Shareholding and investment profile for Shilpa Pranaykumar Patre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilpa Pranaykumar Patre

Shilpa Pranaykumar Patre currently holds 1 directorship: Ashilp Medpharma Private Limited (Director, since 03 Aug 2023).

Shilpa Pranaykumar Patre was first appointed on 03 Aug 2023 as Director at Ashilp Medpharma Private Limited.

The current boards of Shilpa Pranaykumar Patre's companies include Asitmooni Bhagwan Kamble (Ashilp Medpharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available